London – Researchers found in their new study, published in the New England Journal of Medicine, that Ozempic or Wegovy, drug used for weight loss — semaglutide — might contribute to reducing or completely cutting the insulin shots in people diagnosed with Type 1 diabetes. They analysed information from 10 people with Type 1 diabetes who took the drug. who …
London – AstraZeneca has announced that its daily pill decreases deaths in lung cancer patients by half. The results were talked about at the American Society of Clinical Oncology in Chicago and published in the New England Journal of Medicine. The medication, known as osimertinib and marketed as Tagrisso, targets a particular receptor that promotes the growth of cancer cells. …
